Skip to main content
ARAY
NASDAQ Industrial Applications And Services

Accuray Registers 7 Million Shares for Resale by Lenders Following Distressed Financing

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
8
Price
$0.508
Mkt Cap
$57.6M
52W Low
$0.498
52W High
$2.33
Market data snapshot near publication time

summarizeSummary

Accuray Incorporated filed an S-3 registration statement to allow selling stockholders, primarily institutional lenders, to resell up to 7 million shares of common stock issuable upon the exercise of warrants, a consequence of a recent loan amendment.


check_boxKey Events

  • Resale Registration Initiated

    Accuray filed an S-3 to register 7,000,516 shares of common stock for resale by institutional selling stockholders.

  • Shares from Warrant Exercise

    The registered shares are issuable upon the exercise of various warrants (Penny, Premium, Super Premium) previously issued to lenders as part of a December 2025 loan amendment and a June 2025 financing agreement.

  • No Direct Company Proceeds from Resale

    The company will not receive any proceeds from the sale of these shares by the selling stockholders, only from any cash exercise of the underlying warrants.

  • Significant Potential Dilution

    The registered shares represent approximately 6.3% of the company's current outstanding common stock, adding substantial potential selling pressure.


auto_awesomeAnalysis

This S-3 filing enables institutional lenders, who provided financing to Accuray, to resell approximately 7 million shares of common stock. These shares are derived from warrants issued as part of a loan amendment on December 15, 2025, and a prior financing agreement. While the company will receive proceeds if the warrants are exercised for cash, it will not receive any proceeds from the resale of these shares by the selling stockholders. This registration facilitates the monetization of the warrants by lenders, adding significant potential selling pressure to the stock, especially as the company is currently trading near its 52-week lows and facing severe financial challenges, including restated financials, ongoing losses, and a Nasdaq non-compliance notice. The potential dilution of approximately 6.3% of the current outstanding shares is substantial given the company's distressed state.

At the time of this filing, ARAY was trading at $0.51 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $57.6M. The 52-week trading range was $0.50 to $2.33. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ARAY - Latest Insights

ARAY
Apr 28, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
7
ARAY
Apr 17, 2026, 6:03 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
ARAY
Apr 07, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
7
ARAY
Apr 06, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
8
ARAY
Mar 19, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
ARAY
Feb 27, 2026, 4:11 PM EST
Filing Type: 424B3
Importance Score:
7
ARAY
Feb 17, 2026, 4:19 PM EST
Filing Type: S-3
Importance Score:
8
ARAY
Feb 17, 2026, 6:20 AM EST
Filing Type: 10-Q
Importance Score:
9
ARAY
Feb 17, 2026, 6:18 AM EST
Filing Type: 10-Q/A
Importance Score:
9
ARAY
Feb 17, 2026, 6:17 AM EST
Filing Type: 10-K/A
Importance Score:
9